Companies: 10,795·Total market cap: $144.5T
HeartSciences Inc.

HeartSciences Inc.

HSCSNASDAQHealthcare● Active
$1.84
$-0.10(-5.15%)
Market Cap$3987740
P/E Ratio—
52W High$6.47
52W Low$1.63
Shares OutstandingFinancialsRevenue

HeartSciences Inc. (HSCS) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

HSCS · shares outstanding · updated Jun 8, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
938,257▲ +166.16% YoY Change
FY · as of Apr 30, 2025 · Reported in USD
vs 352,520 in FY 2024
Diluted Shares Outstanding
938,257
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+166.16%
year-over-year
Float (Free Float)
2.0M
publicly tradable shares
90.6% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-08

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+204.6%
2022 → 2025
5-Year CAGRincreasing
+95.2%
2020 → 2025
10-Year CAGR—
—
—
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2025Latest
Diluted Shares: 938,257
938,257
+166.16%
FY 2024
Diluted Shares: 352,520
352,520
+343.39%
FY 2023
Diluted Shares: 79,505
79,505
+139.55%
FY 2022
Diluted Shares: 33,189
33,189
+0.15%
FY 2021
Diluted Shares: 33,138
33,138
+0.00%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs HSCS
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+>999%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+>999%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+>999%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+>999%
#7
HeartSciences Inc.HSCS
HeartSciences Inc.YOU
938,257—

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

HeartSciences Inc. (HSCS) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of April 30, 2025, HeartSciences Inc. reports 938,257 basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

HeartSciences Inc.'s basic shares outstanding (938,257) represents currently issued shares. Diluted shares outstanding (938,257) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

HeartSciences Inc.'s float is 2.0M (90.6% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float2.0M(90.6%)
Outstanding2.2M

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

HeartSciences Inc. (HSCS) shares outstanding history from 2020 to 2025. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

HeartSciences Inc. shares outstanding for the fiscal year ending April 30, 2025 were 938,257, a 166.16% increase year-over-year. HeartSciences Inc. FY 2025 shares outstanding were 938,257, a +166.16% increase from FY 2024.

HeartSciences Inc. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of — — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

HSCS shares outstanding · 4 questions

As of April 30, 2025, HeartSciences Inc. (HSCS) has approximately 938,257 basic shares outstanding and 938,257 diluted shares outstanding. This represents a +166.16% year-over-year increase from FY 2024 (352,520). The increase may reflect equity compensation issuances or secondary offerings.

HSCS shares outstandinghow many shares does HSCS haveHSCS basic shares 2025HSCS diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · HeartSciences Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-08